ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Anti-Migraine Drugs Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-16M3257
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Anti Migraine Drugs Market Insights and Forecast to 2028
BUY CHAPTERS

Global Anti-Migraine Drugs Market Research Report 2025

Code: QYRE-Auto-16M3257
Report
September 2025
Pages:97
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Eli Lilly
Eisai Co Ltd
Allergan plc
Endo
GlaxoSmithKline PLC
Impax Laboratories
Pfizer Inc
Astrazeneca plc
Bayer
Johnson & Johnson
Merck
TEVA
Amgen Inc
Abbott
Johnson & Johnson

Anti-Migraine Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Anti-Migraine Drugs Market

Anti-Migraine Drugs Market

The global market for Anti-Migraine Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Anti-Migraine Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Migraine Drugs.
The Anti-Migraine Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Anti-Migraine Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-Migraine Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Anti-Migraine Drugs Market Report

Report Metric Details
Report Name Anti-Migraine Drugs Market
CAGR 5%
Segment by Type
  • Triptans
  • Ergots
  • Others
Segment by Application
  • Women
  • Men
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Eli Lilly, Abbott, Eisai, Allergan, Endo, GlaxoSmithKline, Impax Laboratories, Pfizer, AstraZeneca, Bayer, Johnson & Johnson, Merck, Teva, Amgen
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Anti-Migraine Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Anti-Migraine Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Anti-Migraine Drugs Market report?

Ans: The main players in the Anti-Migraine Drugs Market are Eli Lilly, Abbott, Eisai, Allergan, Endo, GlaxoSmithKline, Impax Laboratories, Pfizer, AstraZeneca, Bayer, Johnson & Johnson, Merck, Teva, Amgen

What are the Application segmentation covered in the Anti-Migraine Drugs Market report?

Ans: The Applications covered in the Anti-Migraine Drugs Market report are Women, Men

What are the Type segmentation covered in the Anti-Migraine Drugs Market report?

Ans: The Types covered in the Anti-Migraine Drugs Market report are Triptans, Ergots, Others

1 Anti-Migraine Drugs Market Overview
1.1 Product Definition
1.2 Anti-Migraine Drugs by Type
1.2.1 Global Anti-Migraine Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Triptans
1.2.3 Ergots
1.2.4 Others
1.3 Anti-Migraine Drugs by Application
1.3.1 Global Anti-Migraine Drugs Market Value by Application (2024 VS 2031)
1.3.2 Women
1.3.3 Men
1.4 Global Anti-Migraine Drugs Market Size Estimates and Forecasts
1.4.1 Global Anti-Migraine Drugs Revenue 2020-2031
1.4.2 Global Anti-Migraine Drugs Sales 2020-2031
1.4.3 Global Anti-Migraine Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Anti-Migraine Drugs Market Competition by Manufacturers
2.1 Global Anti-Migraine Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Anti-Migraine Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Anti-Migraine Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Anti-Migraine Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Anti-Migraine Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti-Migraine Drugs, Product Type & Application
2.7 Global Key Manufacturers of Anti-Migraine Drugs, Date of Enter into This Industry
2.8 Global Anti-Migraine Drugs Market Competitive Situation and Trends
2.8.1 Global Anti-Migraine Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Anti-Migraine Drugs Players Market Share by Revenue
2.8.3 Global Anti-Migraine Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Anti-Migraine Drugs Market Scenario by Region
3.1 Global Anti-Migraine Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Anti-Migraine Drugs Sales by Region: 2020-2031
3.2.1 Global Anti-Migraine Drugs Sales by Region: 2020-2025
3.2.2 Global Anti-Migraine Drugs Sales by Region: 2026-2031
3.3 Global Anti-Migraine Drugs Revenue by Region: 2020-2031
3.3.1 Global Anti-Migraine Drugs Revenue by Region: 2020-2025
3.3.2 Global Anti-Migraine Drugs Revenue by Region: 2026-2031
3.4 North America Anti-Migraine Drugs Market Facts & Figures by Country
3.4.1 North America Anti-Migraine Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Anti-Migraine Drugs Sales by Country (2020-2031)
3.4.3 North America Anti-Migraine Drugs Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Anti-Migraine Drugs Market Facts & Figures by Country
3.5.1 Europe Anti-Migraine Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Anti-Migraine Drugs Sales by Country (2020-2031)
3.5.3 Europe Anti-Migraine Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-Migraine Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Anti-Migraine Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Anti-Migraine Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Anti-Migraine Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Anti-Migraine Drugs Market Facts & Figures by Country
3.7.1 Latin America Anti-Migraine Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Anti-Migraine Drugs Sales by Country (2020-2031)
3.7.3 Latin America Anti-Migraine Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Anti-Migraine Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-Migraine Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Anti-Migraine Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Anti-Migraine Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Anti-Migraine Drugs Sales by Type (2020-2031)
4.1.1 Global Anti-Migraine Drugs Sales by Type (2020-2025)
4.1.2 Global Anti-Migraine Drugs Sales by Type (2026-2031)
4.1.3 Global Anti-Migraine Drugs Sales Market Share by Type (2020-2031)
4.2 Global Anti-Migraine Drugs Revenue by Type (2020-2031)
4.2.1 Global Anti-Migraine Drugs Revenue by Type (2020-2025)
4.2.2 Global Anti-Migraine Drugs Revenue by Type (2026-2031)
4.2.3 Global Anti-Migraine Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Anti-Migraine Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Anti-Migraine Drugs Sales by Application (2020-2031)
5.1.1 Global Anti-Migraine Drugs Sales by Application (2020-2025)
5.1.2 Global Anti-Migraine Drugs Sales by Application (2026-2031)
5.1.3 Global Anti-Migraine Drugs Sales Market Share by Application (2020-2031)
5.2 Global Anti-Migraine Drugs Revenue by Application (2020-2031)
5.2.1 Global Anti-Migraine Drugs Revenue by Application (2020-2025)
5.2.2 Global Anti-Migraine Drugs Revenue by Application (2026-2031)
5.2.3 Global Anti-Migraine Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Anti-Migraine Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Eli Lilly
6.1.1 Eli Lilly Company Information
6.1.2 Eli Lilly Description and Business Overview
6.1.3 Eli Lilly Anti-Migraine Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Eli Lilly Anti-Migraine Drugs Product Portfolio
6.1.5 Eli Lilly Recent Developments/Updates
6.2 Abbott
6.2.1 Abbott Company Information
6.2.2 Abbott Description and Business Overview
6.2.3 Abbott Anti-Migraine Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Abbott Anti-Migraine Drugs Product Portfolio
6.2.5 Abbott Recent Developments/Updates
6.3 Eisai
6.3.1 Eisai Company Information
6.3.2 Eisai Description and Business Overview
6.3.3 Eisai Anti-Migraine Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Eisai Anti-Migraine Drugs Product Portfolio
6.3.5 Eisai Recent Developments/Updates
6.4 Allergan
6.4.1 Allergan Company Information
6.4.2 Allergan Description and Business Overview
6.4.3 Allergan Anti-Migraine Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Allergan Anti-Migraine Drugs Product Portfolio
6.4.5 Allergan Recent Developments/Updates
6.5 Endo
6.5.1 Endo Company Information
6.5.2 Endo Description and Business Overview
6.5.3 Endo Anti-Migraine Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Endo Anti-Migraine Drugs Product Portfolio
6.5.5 Endo Recent Developments/Updates
6.6 GlaxoSmithKline
6.6.1 GlaxoSmithKline Company Information
6.6.2 GlaxoSmithKline Description and Business Overview
6.6.3 GlaxoSmithKline Anti-Migraine Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 GlaxoSmithKline Anti-Migraine Drugs Product Portfolio
6.6.5 GlaxoSmithKline Recent Developments/Updates
6.7 Impax Laboratories
6.7.1 Impax Laboratories Company Information
6.7.2 Impax Laboratories Description and Business Overview
6.7.3 Impax Laboratories Anti-Migraine Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Impax Laboratories Anti-Migraine Drugs Product Portfolio
6.7.5 Impax Laboratories Recent Developments/Updates
6.8 Pfizer
6.8.1 Pfizer Company Information
6.8.2 Pfizer Description and Business Overview
6.8.3 Pfizer Anti-Migraine Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Pfizer Anti-Migraine Drugs Product Portfolio
6.8.5 Pfizer Recent Developments/Updates
6.9 AstraZeneca
6.9.1 AstraZeneca Company Information
6.9.2 AstraZeneca Description and Business Overview
6.9.3 AstraZeneca Anti-Migraine Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 AstraZeneca Anti-Migraine Drugs Product Portfolio
6.9.5 AstraZeneca Recent Developments/Updates
6.10 Bayer
6.10.1 Bayer Company Information
6.10.2 Bayer Description and Business Overview
6.10.3 Bayer Anti-Migraine Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Bayer Anti-Migraine Drugs Product Portfolio
6.10.5 Bayer Recent Developments/Updates
6.11 Johnson & Johnson
6.11.1 Johnson & Johnson Company Information
6.11.2 Johnson & Johnson Description and Business Overview
6.11.3 Johnson & Johnson Anti-Migraine Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Johnson & Johnson Anti-Migraine Drugs Product Portfolio
6.11.5 Johnson & Johnson Recent Developments/Updates
6.12 Merck
6.12.1 Merck Company Information
6.12.2 Merck Description and Business Overview
6.12.3 Merck Anti-Migraine Drugs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Merck Anti-Migraine Drugs Product Portfolio
6.12.5 Merck Recent Developments/Updates
6.13 Teva
6.13.1 Teva Company Information
6.13.2 Teva Description and Business Overview
6.13.3 Teva Anti-Migraine Drugs Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Teva Anti-Migraine Drugs Product Portfolio
6.13.5 Teva Recent Developments/Updates
6.14 Amgen
6.14.1 Amgen Company Information
6.14.2 Amgen Description and Business Overview
6.14.3 Amgen Anti-Migraine Drugs Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Amgen Anti-Migraine Drugs Product Portfolio
6.14.5 Amgen Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-Migraine Drugs Industry Chain Analysis
7.2 Anti-Migraine Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-Migraine Drugs Production Mode & Process Analysis
7.4 Anti-Migraine Drugs Sales and Marketing
7.4.1 Anti-Migraine Drugs Sales Channels
7.4.2 Anti-Migraine Drugs Distributors
7.5 Anti-Migraine Drugs Customer Analysis
8 Anti-Migraine Drugs Market Dynamics
8.1 Anti-Migraine Drugs Industry Trends
8.2 Anti-Migraine Drugs Market Drivers
8.3 Anti-Migraine Drugs Market Challenges
8.4 Anti-Migraine Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Eli Lilly
Eisai Co Ltd
Allergan plc
Endo
GlaxoSmithKline PLC
Impax Laboratories
Pfizer Inc
Astrazeneca plc
Bayer
Johnson & Johnson
Merck
TEVA
Amgen Inc
Abbott
Johnson & Johnson
List of Tables
 Table 1. Global Anti-Migraine Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Anti-Migraine Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Anti-Migraine Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Anti-Migraine Drugs Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Anti-Migraine Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Anti-Migraine Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Anti-Migraine Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Anti-Migraine Drugs Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Anti-Migraine Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Anti-Migraine Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Anti-Migraine Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Anti-Migraine Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Anti-Migraine Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Migraine Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Anti-Migraine Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Anti-Migraine Drugs Sales by Region (2020-2025) & (K Units)
 Table 18. Global Anti-Migraine Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Anti-Migraine Drugs Sales by Region (2026-2031) & (K Units)
 Table 20. Global Anti-Migraine Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Anti-Migraine Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Anti-Migraine Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Anti-Migraine Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Anti-Migraine Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Anti-Migraine Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Anti-Migraine Drugs Sales by Country (2020-2025) & (K Units)
 Table 27. North America Anti-Migraine Drugs Sales by Country (2026-2031) & (K Units)
 Table 28. North America Anti-Migraine Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Anti-Migraine Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Anti-Migraine Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Anti-Migraine Drugs Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Anti-Migraine Drugs Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Anti-Migraine Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Anti-Migraine Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Anti-Migraine Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Anti-Migraine Drugs Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Anti-Migraine Drugs Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Anti-Migraine Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Anti-Migraine Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Anti-Migraine Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Anti-Migraine Drugs Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Anti-Migraine Drugs Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Anti-Migraine Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Anti-Migraine Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Anti-Migraine Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Anti-Migraine Drugs Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Anti-Migraine Drugs Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Anti-Migraine Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Anti-Migraine Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Anti-Migraine Drugs Sales (K Units) by Type (2020-2025)
 Table 51. Global Anti-Migraine Drugs Sales (K Units) by Type (2026-2031)
 Table 52. Global Anti-Migraine Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Anti-Migraine Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Anti-Migraine Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Anti-Migraine Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Anti-Migraine Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Anti-Migraine Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Anti-Migraine Drugs Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Anti-Migraine Drugs Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Anti-Migraine Drugs Sales (K Units) by Application (2020-2025)
 Table 61. Global Anti-Migraine Drugs Sales (K Units) by Application (2026-2031)
 Table 62. Global Anti-Migraine Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Anti-Migraine Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Anti-Migraine Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Anti-Migraine Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Anti-Migraine Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Anti-Migraine Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Anti-Migraine Drugs Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Anti-Migraine Drugs Price (USD/Pcs) by Application (2026-2031)
 Table 70. Eli Lilly Company Information
 Table 71. Eli Lilly Description and Business Overview
 Table 72. Eli Lilly Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. Eli Lilly Anti-Migraine Drugs Product
 Table 74. Eli Lilly Recent Developments/Updates
 Table 75. Abbott Company Information
 Table 76. Abbott Description and Business Overview
 Table 77. Abbott Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. Abbott Anti-Migraine Drugs Product
 Table 79. Abbott Recent Developments/Updates
 Table 80. Eisai Company Information
 Table 81. Eisai Description and Business Overview
 Table 82. Eisai Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. Eisai Anti-Migraine Drugs Product
 Table 84. Eisai Recent Developments/Updates
 Table 85. Allergan Company Information
 Table 86. Allergan Description and Business Overview
 Table 87. Allergan Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Allergan Anti-Migraine Drugs Product
 Table 89. Allergan Recent Developments/Updates
 Table 90. Endo Company Information
 Table 91. Endo Description and Business Overview
 Table 92. Endo Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. Endo Anti-Migraine Drugs Product
 Table 94. Endo Recent Developments/Updates
 Table 95. GlaxoSmithKline Company Information
 Table 96. GlaxoSmithKline Description and Business Overview
 Table 97. GlaxoSmithKline Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 98. GlaxoSmithKline Anti-Migraine Drugs Product
 Table 99. GlaxoSmithKline Recent Developments/Updates
 Table 100. Impax Laboratories Company Information
 Table 101. Impax Laboratories Description and Business Overview
 Table 102. Impax Laboratories Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 103. Impax Laboratories Anti-Migraine Drugs Product
 Table 104. Impax Laboratories Recent Developments/Updates
 Table 105. Pfizer Company Information
 Table 106. Pfizer Description and Business Overview
 Table 107. Pfizer Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 108. Pfizer Anti-Migraine Drugs Product
 Table 109. Pfizer Recent Developments/Updates
 Table 110. AstraZeneca Company Information
 Table 111. AstraZeneca Description and Business Overview
 Table 112. AstraZeneca Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 113. AstraZeneca Anti-Migraine Drugs Product
 Table 114. AstraZeneca Recent Developments/Updates
 Table 115. Bayer Company Information
 Table 116. Bayer Description and Business Overview
 Table 117. Bayer Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 118. Bayer Anti-Migraine Drugs Product
 Table 119. Bayer Recent Developments/Updates
 Table 120. Johnson & Johnson Company Information
 Table 121. Johnson & Johnson Description and Business Overview
 Table 122. Johnson & Johnson Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 123. Johnson & Johnson Anti-Migraine Drugs Product
 Table 124. Johnson & Johnson Recent Developments/Updates
 Table 125. Merck Company Information
 Table 126. Merck Description and Business Overview
 Table 127. Merck Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 128. Merck Anti-Migraine Drugs Product
 Table 129. Merck Recent Developments/Updates
 Table 130. Teva Company Information
 Table 131. Teva Description and Business Overview
 Table 132. Teva Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 133. Teva Anti-Migraine Drugs Product
 Table 134. Teva Recent Developments/Updates
 Table 135. Amgen Company Information
 Table 136. Amgen Description and Business Overview
 Table 137. Amgen Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 138. Amgen Anti-Migraine Drugs Product
 Table 139. Amgen Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. Anti-Migraine Drugs Distributors List
 Table 143. Anti-Migraine Drugs Customers List
 Table 144. Anti-Migraine Drugs Market Trends
 Table 145. Anti-Migraine Drugs Market Drivers
 Table 146. Anti-Migraine Drugs Market Challenges
 Table 147. Anti-Migraine Drugs Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Anti-Migraine Drugs
 Figure 2. Global Anti-Migraine Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Anti-Migraine Drugs Market Share by Type: 2024 & 2031
 Figure 4. Triptans Product Picture
 Figure 5. Ergots Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Anti-Migraine Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Anti-Migraine Drugs Market Share by Application: 2024 & 2031
 Figure 9. Women
 Figure 10. Men
 Figure 11. Global Anti-Migraine Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Anti-Migraine Drugs Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Anti-Migraine Drugs Sales (2020-2031) & (K Units)
 Figure 14. Global Anti-Migraine Drugs Average Price (USD/Pcs) & (2020-2031)
 Figure 15. Anti-Migraine Drugs Report Years Considered
 Figure 16. Anti-Migraine Drugs Sales Share by Manufacturers in 2024
 Figure 17. Global Anti-Migraine Drugs Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Anti-Migraine Drugs Players: Market Share by Revenue in Anti-Migraine Drugs in 2024
 Figure 19. Anti-Migraine Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Anti-Migraine Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Anti-Migraine Drugs Sales Market Share by Country (2020-2031)
 Figure 22. North America Anti-Migraine Drugs Revenue Market Share by Country (2020-2031)
 Figure 23. U.S. Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Anti-Migraine Drugs Sales Market Share by Country (2020-2031)
 Figure 26. Europe Anti-Migraine Drugs Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Anti-Migraine Drugs Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Anti-Migraine Drugs Revenue Market Share by Region (2020-2031)
 Figure 34. China Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Taiwan Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Philippines Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Anti-Migraine Drugs Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Anti-Migraine Drugs Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Anti-Migraine Drugs Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Anti-Migraine Drugs Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. U.A.E Anti-Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Anti-Migraine Drugs by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Anti-Migraine Drugs by Type (2020-2031)
 Figure 56. Global Anti-Migraine Drugs Price (USD/Pcs) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Anti-Migraine Drugs by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Anti-Migraine Drugs by Application (2020-2031)
 Figure 59. Global Anti-Migraine Drugs Price (USD/Pcs) by Application (2020-2031)
 Figure 60. Anti-Migraine Drugs Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Migraine Drugs Market Research Report 2025
Global Oral Migraine Drugs Market Research Report 2025
Antidepressants Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Over the Counter Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Prescription Pain Relievers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Prescription Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Anti Hypertensive Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Depression Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
OTC Anti nausea Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Generic Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Insomnia Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cluster Headache Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Anti influenza Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Alzheimer Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pain Relievers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pain Relief Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Insomnia Therapeutics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Super Generic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Antiallergics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Antipyretic and Analgesic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions